Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9

Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9

BackgroundWe evaluated preoperative CA 19-9 levels in patients with resected pancreatic cancer to analyze whether they were predictive of clinical outcomes and could help select patients for additional therapy. We hypothesized that elevated CA 19-9 would be associated with worse pathologic findings...

Full description

Bibliographic Details
Main Authors: Roman O. Kowalchuk, Scott C. Lester, Rondell P. Graham, William S. Harmsen, Lizhi Zhang, Thorvardur R. Halfdanarson, Rory L. Smoot, Hunter C. Gits, Wen Wee Ma, Dawn Owen, Amit Mahipal, Robert C. Miller, Michelle A. Neben Wittich, Sean P. Cleary, Robert R. McWilliams, Michael G. Haddock, Christopher L. Hallemeier, Mark J. Truty, Kenneth W. Merrell
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
pancreatic cancer
CA19-9
prognostic factors
neoadjuvant
resection
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.651119/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.651119/full

Similar Items